News
The internet was a very different place in the '90s, and one game free on Amazon Prime captures its weird spirit in an even ...
Akebia plans to initiate the Phase III VALOR trial for Vafseo in non-dialysis CKD patients in H2 2025. The trial design is being finalized in consultation with the FDA.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results